Best Paulding County Grants for Nonprofits in Ohio

The Investigator Initiated Research (IIR) Grants program by the Anesthesia Patient Safety Foundation aims to enhance patient safety in anesthesia care through innovative research. Grants up to $200,000 (or $300,000 with waiver) are available for projects addressing critical safety issues, with a focus on studies leading to measurable improvements in outcomes. The program encourages collaboration and creativity, prioritizing research that lacks alternative funding sources, while also supporting junior investigators with mentorship opportunities.

The Quality Improvement Awards, sponsored by the Anesthesia Patient Safety Foundation (APSF), aim to enhance patient safety during anesthesia care. This initiative invites current trainees and recent graduates to showcase their quality improvement projects. Winners will receive sponsorship to attend the Stoelting Conference in Massachusetts, where they will present their work. The APSF is committed to promoting a culture of safety and learning in anesthesia, ensuring that no one is harmed by anesthesia care.

The American Society for Theatre Research (ASTR) David Keller Travel Grants support untenured scholars with terminal degrees in attending the annual ASTR conference. With up to three $800 honorariums and complimentary registration, the grants aim to foster active participation in the organization. Eligible recipients include independent scholars and adjunct faculty, with selection based on their interest and achievements in scholarship and service. This initiative enhances networking and professional development within the theatre research community.

The Sidney R. Baer, Jr. Foundation offers Reintegration Grants aimed at supporting individuals with schizophrenia and bipolar disorder. By focusing on abilities rather than symptoms, the foundation promotes recovery through various programs. Their funding helps organizations that maintain a commitment to mental health, ensuring that recipients receive necessary support, such as scholarships and facility management, to enhance their quality of life. The foundation believes in empowering individuals to actively participate in their recovery journey.

The Sidney R. Baer, Jr. Foundation offers Social Support Grants aimed at improving the lives of individuals living with schizophrenia and bipolar disorder. These grants focus on reducing stigma through education and advocacy, fostering a compassionate environment. The foundation prioritizes organizations that provide tangible support and resources, ensuring a meaningful impact on mental health. By addressing the challenges faced by those with mental illness, the foundation strives to create a more inclusive society that recognizes and supports their needs.

The Sidney R. Baer, Jr. Foundation offers Clinical Research Grants to support advancements in the treatment and understanding of schizophrenia and bipolar disorder. Focused on organizations with IRS tax-exempt status, these grants aim to enhance mental health services and research. By funding initiatives in cognitive and behavioral sciences, the foundation seeks to improve the lives of those affected by serious mental illness, ensuring they receive the support and resources necessary for a better quality of life.

The Melanoma Career Development Award (CDA) is offered by the Melanoma Research Foundation to support researchers dedicated to melanoma and its prevention. This award is designed for postdoctoral fellows with under five years of experience, research associates, scientists, staff scientists, assistant professors, and those focusing on melanoma prevention. The initiative promotes innovative research to advance understanding and treatment of melanoma, ultimately aiming to reduce its impact.

The Cooperative Education Fund, managed by the Cooperative Development Foundation, offers grants, scholarships, and sponsorships to support cooperative education initiatives. Annually, it allocates between $100,000 and $140,000, providing 10-15 grants ranging from $1,000 to $10,000. Eligible applicants include cooperatives and related organizations within the U.S. The Fund prioritizes research, educational material development, and sponsorship for educational events, ensuring resources remain accessible and non-proprietary.

The Cooperative Development Fund Grant supports cooperative development, research, and technical assistance for cooperatives focused on seniors, international development, and affordable housing. Grants, typically ranging from $20,000 to $30,000, are awarded once a year, with a two-stage application process: a concept paper followed by a full proposal for selected applicants. Up to two grants are awarded annually, with decisions announced shortly after the Advisory Board meeting in January.

The Spark Good: Strengthening Community Local Grants program by the Wal-Mart Foundation empowers local organizations through grants ranging from $250 to $5000. This initiative aims to enhance community welfare by supporting diverse projects, including animal shelters and educational programs. Eligible organizations must have a verified Spark Good account, ensuring funds are allocated effectively to meet local needs and foster community development. Together, we can create lasting impacts through small yet significant actions.

The Therapeutic Giving program by Johnson & Johnson Innovative Medicine focuses on supporting nonprofit organizations that enhance patient access to treatment in cardiovascular and metabolic health. Applications are encouraged for initiatives that promote education, empower patients, and address healthcare disparities. Eligible organizations must be IRS 501(c)(3) certified, with a preference for programs demonstrating measurable outcomes. The funding period for local organizations extends from January to October 15th, while national organizations can apply in September.

The Therapeutic Giving program by Johnson & Johnson Innovative Medicine focuses on enhancing patient access to treatment in cardiovascular and metabolism areas. Nonprofit organizations classified as 501(c)(3) are eligible to apply for funding. The program emphasizes innovative initiatives that address healthcare disparities and improve patient outcomes through education, advocacy, and support services. Applications are evaluated based on design, capacity, and potential impact, with a preference for programs over event-based funding.

The Therapeutic Giving program by Johnson & Johnson focuses on funding initiatives that enhance patient access to treatment and advance health equity, particularly in immunology. Eligible nonprofit organizations can apply for support aimed at improving health outcomes through innovative programs. The initiative prioritizes measurable impacts over fundraising activities, emphasizing the importance of addressing healthcare disparities and promoting disease awareness efforts for diseases like rheumatoid arthritis and psoriasis.

The Therapeutic Giving: Oncology program by Johnson & Johnson focuses on funding initiatives that enhance patient access to treatments and services, promote health equity, and strengthen healthcare workforces. It supports programs that raise disease awareness, empower patients, and improve health systems with measurable outcomes. Eligible applicants include nonprofit organizations with 501(c)(3) status, emphasizing innovative programs addressing healthcare disparities and unmet needs.

The Therapeutic Giving program from Johnson & Johnson Innovative Medicine aims to support local and regional organizations focused on improving patient access to treatment and advancing health equity. Eligible applicants include 501(c)(3) nonprofit organizations, with funding preferences for programs that address significant healthcare disparities, mental health initiatives, and innovative solutions with measurable outcomes. The application period for local organizations runs from March 1 to May 31, while national organizations can apply in September.

The Therapeutic Giving initiative by Johnson & Johnson focuses on funding programs in neuroscience aimed at enhancing patient access to treatments and promoting health equity. Nonprofit organizations classified as 501(c)(3) can apply for support from March 1 to May 31. The initiative emphasizes innovative, measurable programs in areas like Alzheimer’s disease and mental health, prioritizing those that address healthcare disparities and improve quality of life for affected individuals.

The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award supports investigator-initiated clinical trials of natural products, including botanicals and dietary supplements. This funding opportunity aims to validate the pharmacokinetics and bioavailability of these products over three years in a phased approach. Successful trials will provide crucial data for further development and clinical application, emphasizing the importance of scientifically driven research in natural product efficacy.

The NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) promotes innovative clinical trials on natural products, such as botanicals and dietary supplements. This funding opportunity supports studies that demonstrate significant scientific rationale and preliminary evidence for efficacy. Applications can explore various delivery methods and combinations with existing treatments to enhance outcomes. Funding is available for up to three years, aimed at bridging basic science discoveries into practical clinical applications.

The NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) invites applications for mid-phase clinical trials involving natural products like botanicals and dietary supplements. The goal is to advance clinical testing through robust preliminary data, ensuring these products demonstrate measurable impacts on target engagement. Submission deadlines span from March 2024 to October 2026. Applications must focus on optimizing doses and identifying patient responders to inform future efficacy trials, aligning with NCCIH's research priorities.

The American Society for the Prevention of Cruelty to Animals (ASPCA) Open Access Publishing Fund Grant supports research that enhances animal welfare. This grant covers article processing fees for open access, peer-reviewed publications up to $5,000. Eligible applicants include U.S. citizens, residents, and researchers in animal welfare. The fund prioritizes submissions in areas such as cruelty prevention, animal sheltering, and veterinary care access, promoting impactful and innovative research.

The NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award aims to support underrepresented graduate students in neuroscience. This two-phase program facilitates the completion of doctoral dissertations and transitions students to postdoctoral positions, enhancing their career development and fostering their growth into independent neuroscience researchers. Applications are due by 5:00 PM local time of the applicant's organization.

The NEI Small Business Innovation Research (SBIR) Cooperative Agreement aims to support small businesses in conducting early-stage clinical trials that pose greater than minimal risk. The program focuses on Phase I and II trials designed to evaluate interventions for vision disorders. Key deadlines for applications include January 30, 2024, and May 24, 2024, among others. Applicants are encouraged to consult with NEI staff prior to submission to ensure alignment with funding opportunities.

The OTA Member Full Research Grant, offered by the Orthopaedic Trauma Association, aims to fund clinical, translational, or basic research projects related to musculoskeletal trauma. Grants of up to $40,000 per year for two years are available for clinical research, and $25,000 per year for two years for basic research. Eligible applicants include OTA members in good standing, and research must be conducted in North America. The initiative seeks to enhance the quality of care for injured patients.

The OTA Resident Research Grant supports resident-led clinical, translational, or basic research projects aimed at improving orthopaedic trauma care. With a maximum funding of $20,000 for a 12-month period, it encourages innovation and research within North America. Eligible applicants must be orthopaedic residents, ensuring that the projects are driven by their unique perspectives and needs. This initiative promotes diversity and aims to enhance the quality of patient care through education and research.

The PERF: Career Development Grants - CNS Elterman Research Grant, established by the Pediatric Epilepsy Research Foundation in partnership with the Child Neurology Society, supports early-stage investigators in pediatric neurology. Eligible candidates can receive $150,000 over two years to conduct clinical or basic science research. This initiative aims to foster the development of researchers focused on pediatric epilepsy and related conditions, enhancing the field through innovative studies and collaboration.

The PERF: Career Development Grants - CNS Shields Research Grant supports early-stage investigators in pediatric neurology research. Offered by the Pediatric Epilepsy Research Foundation and the Child Neurology Society, this grant provides $150,000 over two years. Eligible applicants must be within 10 years of completing their terminal degree and have not received independent funding. The grant emphasizes clinical research, fostering advancements in the treatment of pediatric neurological conditions.

The PERF: CNS Bridge Grant Program aims to support emerging child neurology researchers by providing essential bridge funding while they seek independent research grants from NIH or CIHR. Established by the Pediatric Epilepsy Research Foundation in collaboration with the Child Neurology Society, this initiative seeks to retain talented investigators in the field of pediatric neurology. Since its inception, the foundation has awarded over $18 million to advance pediatric epilepsy research and related conditions.